VBI Vaccines (NASDAQ:VBIV) inks an agreement with Therapure Biopharma’s manufacturing unit to produce its coronavirus vaccine candidates at the latter’s Ontario site in Canada. Therapure will be responsible for making the vaccine drug substance as well as aseptic fill.
Financial terms are not disclosed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.